AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Labor-Health and Human Services Appropriations seeking Food and Drug Administration (FDA) funding. Communication to Drug Enforcement Administration (DEA) on disposal of controlled substances.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KASEY THOMPSON New | — |
| CHRISTOPHER J TOPOLESKI | — |
Medicare/Medicaid MMM
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center and direct reimbursement under Medicare program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KASEY THOMPSON New | — |
| CHRISTOPHER J TOPOLESKI | — |
Pharmacy PHA
Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to FDA on Drug Shortages Task Force. Communication with Drug Enforcement Administration (DEA) on Central Fill of Controlled Substances. Communication with FDA and Center for Disease Control and Prevention on compounding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KASEY THOMPSON New | — |
| CHRISTOPHER J TOPOLESKI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.